Control Elution Buffer (CEB™)
Microbix’s Control Elution Buffer (CEB™) is a Research Use Only (RUO) product designed to elute PROCEEDx™FLOQ® and REDx™FLOQ® external quality control swabs and stabilize nucleic acid/protein targets, assuring reliable and repeatable swab eluate performance.
Product Highlights
Reliable Recovery
Our elution solution ensures consistent and reliable viral/bacterial recovery prior to testing and analysis.
Stability
Our elution buffers maintain the detectability of all tested targets for at least 48 hours when stored at room temperature (2-30°C) or in the refrigerator (2-8°C).
Compatability
Our solution for swab elution has confirmed performance on commonly used platforms and open systems.
Download Our Full Product Catalogue
Products
Product Name | Catalogue Number | Description |
Control Elution Buffer, 1mL | CEB-64-01 | This 1mL product is a swabs elution buffer stable from 2-30°C, which can sustain the detectability of pathogens during elution and following storage. The formulation of control elution buffer for pathogens includes protein for stabilization, antibiotics to minimize bacterial and fungal contamination, and a buffer to maintain a neutral pH. |
Control Elution Buffer, 3mL | CEB-64-03 | This 3mL product is a swabs elution buffer stable from 2-30°C, which can sustain the detectability of pathogens during elution and following storage. The formulation of control elution buffer for pathogens includes protein for stabilization, antibiotics to minimize bacterial and fungal contamination, and a buffer to maintain a neutral pH. |
Frequently Asked Questions
What is the shelf life of your elution buffer?
The shelf life of our Control Elution Buffer (CEB) is 18 months from the manufacturing date, when the product is stored at 2-30°C.
What fill volumes does your elution solution offer?
The CEB™ panel offers 1mL and 3mL fill volumes.
Does Microbix offer custom sample kits for verification/validation studies and operator training?
Yes, Microbix sells ONBOARDx™ kits. ONBOARDx™ kits can be designed to include CEB™ with PROCEEDx™FLOQ® positive swab samples, providing end users with the necessary materials for swab elution.
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Trusted Quality Control Supplier Simplifies Swab Use for QC
Microbix’s Control Elution Buffer (CEB™) is manufactured under the ISO 13485 Quality Management System and has an 18-month shelf life. This product is an advanced formulation that stabilizes nucleic acid and protein targets while suppressing microbial contamination. The CEB™ panel offers 1mL and 3mL fill volumes.
CEB™ vials can be combined with PROCEEDx™FLOQ® swabs to create a complete, self-contained ONBOARDx™FLOQ® kit for assay verification/validation studies and operator training. Additionally, CEB™ can be used with REDx™FLOQ® external quality control swabs to offer an economical solution for whole process QC, including pre-analytical workflow evaluation.
Speak to a Customer Service Representative
Let our knowledgeable experts help you secure your products today.
News & Insights from Our Diagnostics Experts
Microbix Achieves Essential EU Regulatory Accreditations
Microbix announces that it has upgraded its European Union (“EU”) regulatory compliance for its diagnostic assay quality assessment products (“QAPs™”)....
Microbix Presenting at Muskoka Capital Conference
Microbix will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29...
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
Microbix Biosystems Inc. reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“Q3” and “YTD”) with strong revenues, reflective of ongoing progress to increase ...